Atyr Pharma Files Q1 2025 10-Q
Ticker: ATYR · Form: 10-Q · Filed: May 7, 2025 · CIK: 1339970
| Field | Detail |
|---|---|
| Company | Atyr Pharma Inc (ATYR) |
| Form Type | 10-Q |
| Filed Date | May 7, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, biotech, financials
TL;DR
Atyr Pharma's Q1 2025 10-Q is in. Check financials.
AI Summary
Atyr Pharma Inc. filed its 10-Q for the period ending March 31, 2025. The company, based in San Diego, CA, operates in the biological products sector. Key financial details and operational updates for the first quarter of 2025 are presented in this filing.
Why It Matters
This filing provides investors and stakeholders with the latest financial performance and operational status of Atyr Pharma Inc. for the first quarter of 2025.
Risk Assessment
Risk Level: medium — As a biotech company, Atyr Pharma is subject to inherent risks related to drug development, regulatory approvals, and market competition.
Key Players & Entities
- aTYR PHARMA INC (company) — Filer
- 20250331 (date) — Period of Report
- 20250507 (date) — Filing Date
- SAN DIEGO, CA (location) — Business Address
FAQ
What is the reporting period for this 10-Q filing?
The Conformed Period of Report is 20250331, meaning the filing covers the period ending March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on 20250507.
What is the Standard Industrial Classification for Atyr Pharma Inc.?
The SIC code is 2836, categorized under BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES).
Where is Atyr Pharma Inc. located?
Atyr Pharma Inc.'s business address is 10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA 92121.
What is the SEC File Number for Atyr Pharma Inc.?
The SEC File Number is 001-37378.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 7, 2025 regarding aTYR PHARMA INC (ATYR).